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Abstract
Selenium, an essential biological trace element, is an integral component of several enzymes, and its use as a nutritional
supplement has been popularized recently due to its potential role in low concentrations as an antioxidant and in higher
concentrations as an anticancer agent. Selenium has also been reported to act as an insulin-mimetic agent with regard to
normalization of blood glucose levels and regulation of some insulin-mediated metabolic processes. Little work, however,
 .has been done concerning the pathway s by which this insulin-mimetic action occurs. In this study, we investigated the
mechanism by which selenate exhibits insulin-mimetic properties in two different insulin responsive cell types, primary rat
hepatocytes and 3T3 L1 adipocytes. We found that two proteins associated with the insulin signal cascade, the b-subunit of
the insulin receptor and IRS-1, increased in tyrosyl phosphorylation in the presence of selenium. The third identified
selenium activated signal protein, MAP kinase, has been implicated not only in the insulin signal transduction pathway but
also in other growth factor-mediated responses. Using an in-gel activity assay for MAP kinase, we demonstrated that both
the p42 and p44 MAP kinases are activated when either hepatocytes or adipocytes are incubated in the presence of selenate.
In addition to the activation of these specific proteins, we found that selenium also eventually profoundly affected overall
tyrosyl phosphorylation. Our results therefore show that selenium not only increased the phosphorylation of proteins
identified in the insulin signal cascade but also affected the overall phosphorylation state of the cell.
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1. Introduction
 .Selenium Se , an essential biological trace ele-
ment, is an integral component of several enzymes
w x1,2 . Studies have focused on not only the relevant
biological role selenium plays in metabolism but also
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its potential role in low concentrations as an antioxi-
w xdant 3,4 and in higher concentrations as an anti-
w xcancer 5 agent. As an antioxidant, Se stimulates
glutathione peroxidase activity, an enzyme that cat-
w xalyzes the destruction of hydroperoxides 4 . At high
concentrations, selenium’s ability to generate free
w xradicals may account for its anticancer effect 5 . The
use of selenium in these regards has been popularized
by its availability either as a nutritional supplement
or in combination with antioxidant vitamins. Re-
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cently, in a new role, selenium has also been shown
to have insulin-mimetic properties. In insulin-respon-
sive tissues such as rat adipocytes in culture, selenate
affects glucose transport and translocation of glucose
w xtransporters 6 . In diabetic animals, treatment with
selenium effectively normalizes blood glucose levels
w x7 . Selenate, in a manner similar to insulin, also
positively affects the expression of two key lipogenic
 .enzymes, fatty acid synthase FAS and glucose-6-
 .phosphate dehydrogenase G6PDH , in diabetic ani-
w xmals 8 .
Insulin action is mediated through a tyrosyl phos-
phorylation signal transduction cascade that is initi-
ated at the insulin receptor following interaction with
w xthe hormone 9 . The exact molecular changes that
result in activation of the insulin receptor following
insulin binding are uncertain, but considerable data
suggest that the insulin receptor behaves as a classic
allosteric enzyme undergoing both conformational
changes and multisite modification by phosphoryla-
w xtion 9 . Following ligand-induced autophosphoryla-
tion of the receptor, phosphorylation of endogenous
substrates then occurs to mediate the transmission of
an insulin signalling pathway.
Evidence has accumulated recently with regard to
the identification of some of the early downstream
 .components of insulin signalling pathway s . After
receptor autophosphorylation, a principle substrate of
the insulin receptor, insulin receptor substrate-1 IRS-
.1 , becomes phosphorylated on multiple tyrosine
w xresidues 10 . IRS-1, which is suggested to be essen-
tial for some, if not all, of insulin’s biological re-
w xsponses 11 , in turn recognizes and binds to the Src
 .homology 2 SH2 -domains in various signal proteins
 .such as phosphatidylinositol 3-kinase PI-3 kinase ,
 .and growth factor receptor bound protein-2 GRB-2
w x12 . The information available to date clearly indi-
cates that under a number of different circumstances
a variety of phosphoproteins are activated by insulin.
One identified downstream event of the insulin signal
pathway is activation of mitogen activated protein
 .MAP kinase. MAP kinases are serinerthreonine
kinases that are activated in response to a variety of
growth factors. Activation of the MAP kinase cas-
cade is believed to contribute to amplification and
specificity of other signals that ultimately regulate
w xother cytoplasmic and nuclear events 13 .
Evidence, in some cell types is accumulating to
suggest that activation of MAP kinase correlates with
w xtyrosine phosphorylation 14 , a process that can be
w xmediated by GTP-bound Ras 15 . Ras is required for
Raf-1 activation and Raf-1 is capable of MAP kinase
w xactivation 16 . In vitro experiments have linked Ras
to an insulin signalling pathway through its upstream
 . w xassociations with son of sevenless Sos 17 proteins
w xand GRB 2 18 . GRB 2 is essential in the transmis-
sion of signal between tyrosine kinases and Ras
w xactivation 19 . The exact role, however, that MAP
kinase or any of these signal proteins plays in an
insulin stimulated metabolic or mitogenic response is
still unclear. Even less clear is the role that activation
of any of these phosphoproteins may play in an
insulin-mimetic signal pathway.
While selenate has been shown to be a potent
w xinsulin-mimetic in isolated adipocytes 6 and in vivo
w x7,8 , little work has been done concerning the path-
 .way s by which this action occurs. In this study, we
investigated the mechanism by which selenate ex-
hibits insulin-mimetic properties in two different in-
sulin responsive cell types, primary rat hepatocytes
and 3T3 L1 adipocytes, and found that in both cases
selenate’s action increased not only protein substrates
that ultimately led to activation of MAP kinase but
also eventually overall tyrosyl phosphorylation.
2. Materials and methods
2.1. Hepatocyte isolation and maintenance
Hepatocytes were isolated using collagenase,
hyaluronidase perfusion as described by Elliget and
w xKolaja 20 , with the following modifications. The
protocol used for the animal work was approved by
the Institutional Animal Care and Use Committee and
complied with the Guide for the Care and Use of
Laboratory Animals. Male Sprague-Dawley rats
 .Harlan Sprague-Dawley, Kalamazoo, MI weighing
200–300 g were food-deprived 48 h prior to the
isolation procedure. Rats were anesthetized with 50
mgrml pentabarbitol. After collagenase perfusion,
the liver was excised and forced through four layers
of sterile gauze. The cells were washed two times
with cold serum-free Waymouth’s MB 752r1
 .medium Gibco BRL, Grand Island, New York and
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pelleted for 3 min at 48C and 50 g. The pellet was
gently resuspended in medium and an aliquot of cells
counted with a hemocytometer. Cell viability was
determined by trypan blue dye exclusion. Collagen
coated 60 mm tissue culture dishes were plated with
3.0=106 cellsrplate. The cells were incubated in
serum-free Waymouth’s MB 752r1 medium supple-
 .mented with gentamicin 10 mgrml under a humidi-
fied atmosphere of 5% CO and 95% air at 378C.2
After about 4 h of incubation, the cells were washed
and fresh medium applied. With this fresh serum-free
medium change, insulin or sodium selenate was added
at the concentrations and times indicated in figure
legends.
2.2. 3T3-L1 maintenance
The 3T3-L1 cell line was maintained in culture as
w xdescribed previously 21 . Differentiation of confluent
cultures was initiated by incubation of cells in Dul-
 .becco minimal essential media DME containing
 .7.5% fetal calf serum, dexamethasone 1 mM ,
 . isobutyl methyl xanthine 0.5 mM , and insulin 5
.mgrml for 48 h. This media was replaced with
DME containing 7.5% fetal calf serum for 3–4 days,
then placed in serum-free DME for 24 h and then
incubated with either insulin or sodium selenate at
the concentrations and times indicated in figure leg-
ends prior to harvest.
2.3. Enzyme assays
For each condition tested, hepatocytes from two
60-mm plates were pooled. The cells were scraped,
and homogenized for the spectrophotometric mea-
w x w xsurement of G6PDH 22 and FAS 23 . Protein was
w xmeasured by the Lowry method 24 . Cell viability
was assessed by measuring lactate dehydrogenase
Fig. 1. Insulin and selenium dependent increase of tyrosyl phosphorylation. Arrows indicate the location of IRS-1 and the b-subunit of
the insulin receptor. Arrowheads indicate migration of known mol. wt. standard proteins. A. Hepatocytes were treated with either nothing
 .  .  .  .lane 1 , 80 nM insulin lanes 2–5 , 500 mM Se lanes 6–9 , or 1000 mM Se lanes 10 and 11 for the following time periods: 1 min
 .  .  .  .lanes 2 and 6 , 5 min lanes 3, 7 and 10 , 1 h lanes 4, 8 and 11 and 5 h lanes 5 and 9 . B. 3T3-L1 cells were treated with either nothing
 .  .  .  . lane 1 , 80 nM insulin lane 2 , 250 mM Se lanes 3–5 or 1000 mM lanes 6–8 for the following period of times: 5 min lanes 3 and
.  .  .  .6 , 1 h lanes 4 and 7 and 5 h lanes 5 and 8 . C. Semi-purified insulin receptors were isolated from 3T3-L1 cells either untreated lane 1
 .  .or treated with 80 nM insulin for 5 min lane 2 or 1000 mM Se lane 3 for 1 h. D. IRS-1 immunoblot of extracts from 3T3-L1 cells
 .  .  .  .  .treated with either nothing lane 1 , 80 nM insulin for 5 min lane 2 or 5 h lane 3 , 500 mM Se for 1 h lane 4 or 5 h lane 5 or 1000
 .  .mM Se for 1 h lane 6 or 5 h lane 7 .
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w xleakage into the media 25 . Ethidium bromide, fluo-
rescein diacetate double label analysis for cell viabli-
w xity was also carried out on replicate plates 26,27 .
2.4. Glucose uptake experiments
w14 xUptake of C -2-deoxy-D-glucose was measured
in fully differentiated 3T3-L1 adipocytes as described
w xpreviously 21 .
2.5. Western analysis and in-gel MAP kinase assay
After treatment, cells were washed twice with ice
cold PBS. Cells were flash frozen, then scraped and
processed in a buffer containing 20 mM HEPES free
.acid , pH 7.3, 100 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM vanadate, 0.1 mM molybdate, 1 mM
DTT, 10 mM MgCl2, 5 mM p-nitrophenol phos-
phate, 1 mM PMSF, 10 mM b-glycerophosphate, 5
mgrml leupeptin, 5 mgrml pepstatin, 0.5% Triton
w xX-100 and 1 mM NaF 14 . The total cell extracts
were vortexed and centrifuged, and the resulting
post-nuclear extracts were resuspended in SDS-PAGE
sample buffer. For Western analysis, the samples
were electrophoresed in a 12% polyacrylamide gel
and transferred to PVDF membrane using standard
semi-dry electroblotting techniques as described by
the manufacturer, NOVEX, San Diego, California.
After transfer, the membrane was blocked with a 1%
bovine serum albuminrPBS solution. The membrane
was then incubated with the appropriate antibody:
 .anti-phosphotyrosine clone 4G10 , anti-MAP kinase,
 .or anti-IRS-1 carboxy terminal , all from Upstate
Biotechnology, Lake Placid, NY. Detection of the
immunoreactive bands was carried out using the ECL
Western blotting detection system from Amersham,
Arlington Heights, IL.
Analysis of MAP kinase activity was carried out
w xusing a myelin basic protein in-gel activity assay 28 .
The samples were electrophoresed in a 12% poly-
acrylamide gel containing 0.53 mgrml bovine myelin
 .basic protein Gibco BRL . After electrophoresis the
gel was washed sequentially in solutions containing
20% isopropanol in Buffer B 50 mM Tris, pH 8.0,
.and 5 mM b-mercaptoethanol ; Buffer B; and 6 M
guanidine HCl in Buffer B. After the denaturation
step, the gel was washed with 0.04% Triton X-100 in
Buffer B and then in 40 mM Hepes, pH 8.0, 2 mM
DTT and 10 mM MgCl . Finally, the gel was incu-2
bated with 40 mM gamma 32P ATP, rinsed in 5%
TCA and 1% sodium pyrophosphate, dried, and ex-
posed to X-ray film.
Results were quantitated by a scanning densitome-
 .ter Molecular Dynamics, CA .
2.6. Statistical analysis
The results are expressed as the mean"S.E.M.
Significance was evaluated by one-tailed Student’s
t-test. Significance was tested at P-0.05.
3. Results
3.1. Tyrosine phosphorylation
As shown in Fig. 1A, incubation of primary hepa-
tocytes in culture with insulin elicits a rapid phospho-
rylation of the b-subunit of the insulin receptor as
well as IRS-1. This approximate 3- to 4-fold increase
in phosphorylation by insulin reaches a maximum by
Fig. 2. Effect of selenium on lactate dehydrogenase release into
the media. Hepatocytes were either untreated or treated in Way-
mouths media with either 100, 250, 500 or 1000 mM selenium
for up to 10 h. Media from duplicate plates was removed at the
time points indicated and assayed for LDH activity. Results are
expressed as percent of LDH activity in the media from untreated
 .cells control . Data shown are the means"S.E. of three different
sets of cells.
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1 min and then diminishes with time Fig. 1A, lanes
.1–5 . Incubation of primary hepatocytes in culture
with Se show that the metal also causes a concentra-
tion and time-dependent increase in phosphorylation
of the same proteins as insulin Fig. 1A, lanes 6, 7, 8
.and 10 . Increased phosphorylation of the b-subunit
and IRS-1 can be observed within 1 h of Se treat-
ment. An extreme degree of overall phosphorylation
is observed by 5 hours of Se treatment Fig. 1A,
.lanes 9 and 11 . The extreme degree of phosphoryla-
tion caused by Se treatment is not due to a toxic
 .effect since lactate dehydrogenase release Fig. 2
into the medium nor cell viability as accessed by
ethidium bromiderfluorescein diacetate staining re-
.sults not shown did not change under the conditions
tested. To establish that the activation of insulin
signal proteins by Se and the dramatic increase in
phosphorylation is not unique to cells derived from
liver, we examined the influence of the metal on the
insulin signalling cascade and overall tyrosyl phos-
 .phorylation in 3T3-L1 adipocytes Fig. 1B . Clearly,
similarly to the effect observed in hepatocytes, both
 .  .insulin Fig. 1B, lane 2 and Se Fig. 1B, lanes 3–8
increase the phosphorylation of the b-subunit of the
insulin receptor and IRS-1 in 3T3-L1 cells. The same
increase in overall tyrosyl phosphorylation observed
in hepatocytes after 5 h of Se treatment is also
 .observed in the 3T3-L1 cells Fig. 1B, lane 5 and 8 .
To clearly demonstrate increased insulin receptor
phosphorylation, post nuclear extracts from cells ei-
ther untreated or treated with insulin, or Se were used
to partially purify the receptor. Insulin receptors were
semi-purified over wheat germ agglutinin, elec-
trophoresed, and Western blotted with anti-phospho-
tyrosine antibody. Fig. 1C, conclusively shows that
 .both insulin after 1 min lane 2 and Se after 1 h
 .lane 3 increase phosphorylation of the b-subunit of
the insulin receptor. Fig. 1D shows that the increase
in phosphorylation of IRS-1 illustrated in Fig. 1B is
not due to increased protein in the conditions tested
since the same amount of immunoblotted IRS-1 pro-
tein is observed in each lane hence, insulin and Se
clearly increase IRS-1 phosphorylation.
3.2. MAP kinase acti˝ation
In Fig. 3A, we show using an ‘in-gel activity
 .  .assay’ that insulin lane 4 and Se lanes 5–7 acti-
Fig. 3. Activation of MAP kinase by insulin and selenium. MAP
activity was assessed using the in gel activity assay in A and C
and mobility shift analysis of the isoforms in B. Arrows indicate
the p42 and p44 isoforms of MAP kinase. Arrowheads indicate
migration of known molecular weight standard proteins. A. Lane
1 shows MAP kinase activity in 3T3-L1 cells treated with 80 nM
insulin for 5 min. Lane 2 is blank. Lanes 3–7 illustrate MAP
kinase activity in hepatocytes. Hepatocytes were either untreated
 .  .lane 3 , or treated with 80 nM insulin lane 4 or 500 mM Se for
 .  .  .5 min lane 5 , 1 h lane 6 , or 5 h lane 7 . B. Hepatocytes were
 .  .incubated in the absence lane 1 or presence lane 2 of 80 nM
 .insulin for 5 min or in the presence of 500 mM Se lanes 3–6 or
 .1000 mM Se lanes 7 and 8 at the following time periods: 1 min
 .  .  . lane 3 , 5 min lanes 4 and 7 , 1 h lanes 5 and 8 and 5 h lane
.  .6 . 3C. 3T3-L1 cells were either untreated lane 1 or treated with
 .  .80 nM insulin for 5 min lane 2 , 250 mM Se lanes 3–5 or
 .1000 mM Se lanes 6–8 for the following time periods: 5 min
 .  .  .lanes 2, 3 and 6 , 1 h lanes 4 and 7 or 5 h lanes 5 and 8 .
vate both the p42 and p44 isoforms of MAP kinase in
hepatocytes. Quantification of the results by scanning
densitometry showed that insulin increased the p44
MAP kinase activity more than 2-fold within 5 min
 .of treatment Fig. 3A, lane 4 . Se increased p44 MAP
 .kinase activity greater than 6-fold by 5 h Fig. 4 .
This activation of the MAP kinases in hepatocytes by
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Fig. 4. Selenium dependent increase in p44 MAP kinase activity
in rat hepatocytes and 3T3-L1 cells. Results from Fig. 3A,
incubation of rat hepatocytes with 500 mM Se and Fig. 3C,
incubation of 3T3-L1 cells with 1000 mM Se, are quantified by
scanning densitometry.
insulin and Se is also clearly demonstrated when
monitored by the electrophoretic shift of the bands
 .when phosphorylated Fig. 3B . An increase in the
phosphorylation state of the protein slows the migra-
tion of both the p42 and p44 isoforms through the gel
as is evident when cells are treated with insulin for 5
 .min Fig. 3B, lane 2 and when cells are treated with
 .500 mM Se for 1 and 5 h Fig. 3B, lanes 5 and 6
 .and with 1000 mM Se for 1 h Fig. 3B, lane 8 .
In 3T3-L1 adipocytes, increased phosphorylation
of p44 MAP kinase is also noted in the presence of
both insulin and Se. Results from the in-gel acitivity
assay show that within 5 min of incubation, insulin
increased the p44 MAP kinase activity greater than
 .20-fold Fig. 3C, lane 2 . Selenium induced phospho-
rylation of MAP kinases in adipocytes is both con-
centration and time dependent with greater than a
Fig. 5. Concentration and time dependent increase in glucose
uptake in 3T3-L1 cells. 5A. 3T3-L1 cells were incubated at the
w14 xindicated concentration of sodium selenate for 2 h and C -2-
deoxy-D-glucose uptake was measured. 5B. Similarly, 3T3-L1
cells were incubated with 250 mM Se for the incubated times.
Control cells were treated with 80 nM insulin for 10 min solid
.box . Each point represents the mean"S.E. of 5 determinations.
25-fold activation of p44 MAP activity following five
hours of treatment with the highest level of selenium
 .Fig. 4 . Therefore, incubation of either cell type with
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Se causes an increase in the phosphorylation state of
MAP kinase although the kinetics and fold of induc-
tion of this increase differs from that observed with
the hormone. While insulin within minutes rapidly
increases MAP kinase phosphorylation, incubation
with Se increases MAP kinase activity more slowly
and in a fashion that leaves it in the active state for
several hours.
3.3. Glucose uptake
Increased glucose transport in muscle and adipose
tissue is a hallmark of insulin action. In the experi-
ment shown in Fig. 5 we examined the ability of Se
to increase glucose uptake in 3T3-L1 adipocytes. Se
 .treatment elicited both a concentration Fig. 5A and
 .time Fig. 5B dependent increase in glucose uptake.
 .Incubation for even a short time 10 min signifi-
 .cantly P-0.05 increased glucose uptake over con-
trol uptake while maximum effects required several
hours. The highest rate of transport achieved with Se
treatment was nearly comparable to that observed
with insulin alone and the two agents at maximum
concentration were not additive in their effects, sug-
gesting that the same process is maximally enhanced
 .in each case data not shown .
3.4. Enzyme acti˝ity
Insulin regulates the expression of many genes
associated with key metabolic enzymes. In the hepa-
tocytes, insulin increases the expression of the genes
Table 1
Insulin and selenium similarly increase the activities of fatty acid
synthase and glucose-6-phosphate dehydrogenase
G6PDH FAS
 .Nothing control 8.2"0.7 1.8"0.4
) )Insulin 23.8"1.5 4.1"0.3
) )Sodium selenate 20.5"2.1 4.0"0.5
Hepatocytes were incubated in Waymouths media with either
nothing, 80 nM insulin, or 20 mM sodium selenate added for 48
h. For each condition tested, two plates were pooled and pro-
cessed for enzyme activity determination. Data shown are the
 .specific activities Urmg protein of the means"S.E. for four
different animals.
) Significantly different from control, P -0.05.
for FAS and G6PDH. Incubation of rat hepatocytes in
 .culture with Se also significantly P-0.05 in-
creased activity for both FAS and G6PDH. The
observed increase in activity with the addition of Se
in culture is comparable to the increases observed
when hepatocytes are incubated with insulin Table
.1 .
4. Discussion
Consistent with previous reports using other cell
w xtypes 9,11,29,30 , our results show that incubation of
primary hepatocytes in culture with insulin elicits a
rapid phosphorylation of the b-subunit of the recep-
tor as well as IRS-1 and this phosphorylation then
diminishes with time. Initiation of this phosphoryla-
tion cascade as others have demonstrated using muta-
tional analysis is critical to the mediation of insulin
w xregulated downstream events 9 . For example, Vogt
w x w xet al. 31 and Wilden et al. 32 have shown that
mutation of the autophosphorylated tyrosine residues
of the receptor results in a parallel loss of insulin
regulated biological activity while Yonezawa et al.
w x33 showed that overexpression of a kinase-negative
mutant insulin receptor is unable to phosphorylate
IRS-1 and subsequent signal proteins.
Since Se has been reported to exhibit insulin-
w xmimetic properties 6–8 , we examined the ability of
it to influence the initiation of this phosphorylation
cascade. Incubation of either hepatocytes or 3T3-L1
adipocytes with Se causes an increase in the phos-
phorylation of both the insulin receptor and IRS-1.
Insulin and Se also stimulate phosphorylation of an-
other protein of approximately 180 kDa that copuri-
fies with the insulin receptor. This band could corre-
 .spond to the epidermal growth factor EGF receptor.
w xPillay and Makgoba 34 have previously shown sele-
nate to stimulate tyrosine phosphorylation of the EGF
receptor in A431 cells, however in their work, con-
centrations of less than 1 mM as we have used were
not effective. Their report also indicated that Se
stimulated the phosphorylation of the insulin receptor
in NIH 3T3 HIR3.5 cells but again concentrations of
1 mM or larger were needed to observe this effect.
Our observed increases in the phosphorylation pattern
of either the receptor or IRS-1 could be due to
increases in protein content in the Western analysis,
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however, no increase in immunoblotted IRS-1 is
observed. Thus, Se appears capable of activating
insulin signal transduction by increasing receptor
autophosphorylation as well as the phosphorylation
of an additional protein, IRS-1, believed to play a
w xrole in insulin signalling 9,10,29,30 . The Se initi-
ated increases observed in phosphorylation of the
insulin receptor and IRS-1 in both cell types are thus
sufficient to account for the subsequent metabolic
events observed, increased glucose uptake in
adipocytes and increased activity levels of both
G6PDH and FAS in hepatocytes.
In 3T3-L1 cells, incubation for even a short time
with Se significantly increases glucose uptake while
maximum effects requires several hours. The highest
rate of transport achieved with Se treatment is nearly
comparable to the increase observed with insulin
alone. Selenate had been previously observed to in-
crease glucose uptake in primary adipocytes, how-
ever, the time and concentration dependence we ob-
served in the 3T3-L1 cells differ. Ezaki reported that
addition of 1 mM selenium stimulated glucose trans-
port activty and its effect was about 50% of the
w xmaximal insulin stimulated transport activity 6 . This
increase in glucose transport was shown to be due to
increased glucose transporter translocation.
In the liver, insulin regulates the expression of
many genes involved in a variety of metabolic pro-
w xcesses 35–37 . The expression of both FAS and
G6PDH in the liver is well documented to be regu-
w x w xlated by insulin 38,39 . Berg et al. 8 have shown
that Se treatment of diabetic animals upregulates the
expression of both FAS and G6PDH similarly to
insulin. Therefore, to monitor selenates effect on
metabolism in the hepatocyte we assayed for insulin-
like increases in activities for FAS and G6PDH. In
the hepatocytes, Se increased activity for both FAS
and G6PDH. The 2- to 3-fold increase in activity
with the addition of Se in culture is comparable to the
increases observed when hepatocytes are incubated
with insulin. Therefore, in hepatocytes, Se mimicks
insulin’s effects on fatty acid metabolism, and this
increase could be mediated by the 2- to 3-fold in-
crease in activation of the insulin receptor and IRS-1.
Surprisingly, incubation of either primary hepato-
cytes or 3T3-L1 cells in culture with Se show that the
metal causes an extreme degree of phosphorylation of
multiple protein species which can be observed after
5 hours of treatment. This effect is not due to over-
loading or overexposure of the sample lanes with Se.
The implication of elevated degrees of phosphoryla-
tion by Se is great as many processes from ion
transport to control of gene transcription by nuclear
factors can be regulated by phosphorylation. The
increase in phosphorylation of tyrosine residues could
be the result of an overall increase in tyrosine kinase
activity within the cell. However, the slow kinetics of
this elevated phosphorylation, hours as opposed to
minutes, may argue that inhibition of a protein tyro-
sine phosphatase may be the primary target of Se.
Studies investigating the catalytic mechanism of pro-
tein-tyrosine phosphatases and dual specific phos-
phatases have identified an invariant active site cys-
teine residue that is essential for enzymatic activity
w x40,41 . In many cases, a phosphoenzyme intermedi-
ate is present during the enzymatic reaction indicat-
ing the formation of a thiophosphate. Activity of
these enzymes is abolished if this cytsteine is re-
w xplaced or somehow compromised 40,41 . It is there-
fore attractive to speculate that selenium interacts
with this necessary cysteine and inhibits phosphatase
activity. This inhibition of phosphatase activity may
also account for the sustained activation of MAP
kinase by selenium.
Selenium has been reported to have toxic effects at
high concentrations, although the mechanism is not
well understood. Studies aimed at elucidating this
mechanism have compared various forms of selenium
on metabolic parameters. In a variety of cell systems
w x42–45 , it has been shown that selenite and seleno-
cystine are the two most highly toxic forms of sele-
nium as measured by lactate dehydrogenase leakage
and thiobarbituric acid assay. Selenite and selenocys-
tine toxicity appears to also be accompanied by a loss
of reduced glutathione suggesting oxygen radicals
w xmay ultimately be responsible for toxicity 42,43 .
Sodium selenate, the form we have used in this study,
and selenomethionine have not shown a loss of re-
duced glutathione nor appear to be as toxic as selen-
w xite or selenocystine in vitro 43,44,46 . Several stud-
ies, including ones in primary hepatocytes, have uti-
lized sodium selenate up to 1000 mM without ad-
w xverse effects 34,43,44,46 . Interestingly, in a study to
determine the cytotoxic effects of selenium com-
pounds on rat erythrocytes, concentrations up to 10
mM sodium selenate were used without noted hemol-
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w xysis 47 . Data accumulated from a variety of studies
has since been used to provide a hypothesis as to why
certain Se compounds are more toxic in vitro than
others. The hypothesis states that Se compounds, i.e.,
selenite and selenium dioxide, can react with glu-
tathione and other thiols to form selenotrisulfides that
will ultimately react to produce superoxide and hy-
drogen peroxide, are toxic. Diselenides that can be
reduced to selenols also produce superoxide and hy-
drogen peroxide and are toxic. In vivo, selenate can
be reduced to selenite when oxidative damage ex-
ceeds antioxidant defenses and hence becomes toxic
w x47 .
Dietary feeding studies however have been done
with concentrations of selenite of up to 250–500 mM
w xwithout severe toxic effects 47,48 and so the con-
centrations utilized in this study are within the range
used in whole animals. It is acknowledged that in
these cells in culture, selenate may be metabolized to
a more toxic species however, the insulin-mimetic
property of selenium in vitro and in vivo has only
been reported with selenate. This is, therefore, the
chemical form of selenium utilized in this study.
Based on all of the above evidence, it is highly
unlikely that the effects we observe are due to a toxic
event but to ensure this we tested two parameters.
The results from the lactate dehydrogenase and dou-
ble label fluorescent dye assays confirm that the
concentrations of selenium used in this study were
not toxic to the cell.
Activation of MAP kinase is an important conse-
quence of interaction of not only insulin but also
w xother growth factors with responsive cells 13,14 .
While stimulation of MAP kinase activity is neces-
sary for growth factor mediated signalling, in some
studies, it does not appear to be sufficient to modu-
late metabolic responses. In 3T3-L1 cells, insulin
stimulated MAP kinase activity only 2.5 fold but
stimulated glucose transport, glycogen synthesis and
w xlipid synthesis 4, 15 and 17 fold, respectively 38 .
EGF and PDGF also stimulated MAP kinase activity
in 3T3-L1 cells but did not stimulate glucose uptake
w x38,39 . We show that insulin activates both the p42
and p44 MAP kinases in hepatocytes and 3T3-L1
adipocytes. The increase in MAP kinase activity in
hepatocytes, 2 fold by insulin and 6 fold by Se is
sufficient in our system for the observed increase in
FAS and G6PDH activity. The additional increase in
MAP kinase activity by Se could be due to an
increase in another signalling mechanism that does
not yield the same metabolic event. In this case, some
other attenuator must be involved. Simultaneous in-
cubation of cells with Se and the tyrosine kinase
inhibitor, genistein, did block the activation of MAP
kinase, demonstrating that the pathway of the activa-
tion of MAP kinase by Se is tyrosine kinase specific.
It is possible that activation of this kinase is the
rate-limiting step in the activation of the MAP ki-
nases by Se and hence the time lag of activation as
compared to the hormone is observed. This activation
of a kinase may also occur if a regulatory phos-
phatase is inhibited. In the adipocytes, both insulin
and Se activate MAP kinase activity at least 20 fold.
This increase is more than expected from the fold
increase observed at the receptor level and more than
is necessary for glucose uptake. With insulin, it is
w xalso more than that reported by Wiese et al. 49
although culture conditions, ie our use of serum free
medium, may explain this discrepancy. Again these
dramatic increases may be due to some other regula-
tory attenuator. Further studies are needed to clarify
these events.
Cellular implications of the observed Se effects
may be profound in that Se, similarly to insulin,
appears to be able to activate the b-subunit of the
insulin receptor, IRS-1 and MAP kinase, suggesting
that the effect on metabolism is via an insulin signal
cascade. This is important if Se is to ever be used
effectively as an insulin-mimetic. Se treatment of
these cell types, however, also overrides normal cel-
lular onroff signals that control phosphorylation cas-
cades as this activation caused by Se is maintained
over hours as opposed to the hormone activation
which is over within minutes. The consequences of
this need to be further studied not only since activa-
tion of the MAP kinase cascade is a common thread
between many growth factor mediated responses but
also because of the ease of accessibility of selenium
as a dietary supplement.
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